| scholarly article | Q13442814 |
| P2093 | author name string | Vinod Pullarkat | |
| Stephen J Forman | |||
| Lawrence M Weiss | |||
| Marilyn L Slovak | |||
| Victoria Bedell | |||
| Karl Gaal | |||
| P2860 | cites work | Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study | Q28139696 |
| Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial | Q31085634 | ||
| Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. | Q34569095 | ||
| Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). | Q35616078 | ||
| Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses | Q35747661 | ||
| Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. | Q35847679 | ||
| Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays | Q35869444 | ||
| Tyramide signal amplification for DNA and mRNA in situ hybridization | Q36509114 | ||
| Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia | Q36523626 | ||
| The changing scene of adult acute lymphoblastic leukemia | Q36599893 | ||
| Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. | Q36684897 | ||
| Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence | Q38436315 | ||
| FISH detection of t(14;18) in follicular lymphoma on Papanicolaou-stained archival cytology slides | Q38437846 | ||
| Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. | Q38447382 | ||
| Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma. | Q40422274 | ||
| Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability | Q40427115 | ||
| Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines | Q40883718 | ||
| A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization | Q42119952 | ||
| Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement | Q42163250 | ||
| Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate | Q44319749 | ||
| Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. | Q44368773 | ||
| Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha | Q45206587 | ||
| Induction of centrosome and chromosome aberrations by imatinib in vitro | Q46577685 | ||
| Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone | Q47592508 | ||
| Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization | Q47619689 | ||
| An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning | Q48921561 | ||
| Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion. | Q53589005 | ||
| Preclinical validation of fluorescence in situ hybridization assays for clinical practice. | Q53640258 | ||
| Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated | Q60203798 | ||
| A comparative study of the quality of DNA obtained from fresh frozen and formalin-fixed decalcified paraffin-embedded bone marrow trephine biopsy specimens using two different methods | Q61847210 | ||
| Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells | Q68080020 | ||
| Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis | Q74531372 | ||
| Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials | Q79345406 | ||
| Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma | Q79560726 | ||
| Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis | Q79739589 | ||
| Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma | Q79780500 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 589-597 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | The Journal of Molecular Diagnostics | Q7743603 |
| P1476 | title | Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections | |
| P478 | volume | 9 |
| Q38389692 | A preliminary study of the suitability of archival bone marrow and peripheral blood smears for diagnosis of CML using fish |
| Q37605365 | Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. |
| Q33840504 | Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma |
Search more.